HealthTech
Secure HealthTech Funding During Expensive Clinical Phases
We've secured $500K+ for HealthTech companies across NIH SBIR and Canadian health innovation programs with an 86% success rate
Claim Your SpotHealthTech Development Costs Are Crushing Innovation
Massive Development Costs
Clinical trials cost $1B+ on average. Non-dilutive funding can bridge the gap between prototype and regulatory approval without giving up equity.
High Failure Rates
90% of health technologies fail to reach market. The right funding strategy de-risks your path and keeps you moving through expensive validation phases.
Regulatory Complexity
FDA pathways take 10+ years on average. Grant funding can accelerate regulatory milestones and provide the data agencies need to clear your technology.
Cross-Border Blindness
$6.4B in Canadian health innovation funding goes untapped by US companies. Our cross-border expertise finds programs most firms miss entirely.
Proven results in HealthTech funding
$42K+ NIH SBIR
Secured NIH SBIR funding for a neurotechnology company, initiating clinical trials for a breakthrough brain-computer interface device.
$60K+ Canadian Health Innovation
Won Canadian health innovation funding for a digital health platform, enabling expansion into remote patient monitoring across multiple provinces.
$41K+ NSF SBIR Phase I
Secured NSF SBIR Phase I funding for a medical device startup, earning FDA breakthrough device designation during the award period.
Our process
Clinical Assessment (Week 1)
We evaluate your technology, regulatory status, clinical data, and competitive landscape to identify the highest-probability funding programs.
Strategy (Weeks 2-4)
We build your funding roadmap, matching your clinical milestones to agency timelines and structuring narratives that reviewers score highly.
Expert Execution (Weeks 5-8)
Our team writes, reviews, and submits your applications with clinical narrative expertise that translates your science into fundable proposals.
Frequently asked questions
Do I need FDA clearance before applying for grants?
No. Most health innovation grants are designed to fund the research and development that leads to FDA clearance. Many programs specifically target pre-submission technologies.
Can pre-clinical companies apply?
Yes. NIH SBIR and other programs fund pre-clinical research, including proof-of-concept studies, animal models, and early feasibility testing.
How do grants support clinical studies?
Grant funding can cover pilot studies, IRB costs, patient recruitment, data analysis, and other clinical trial expenses that would otherwise require dilutive capital.
Can international clinical trials be funded?
Some programs allow international sites, but most US federal grants require primary research to be conducted domestically. Canadian programs have their own jurisdiction requirements.
Ready to Secure Your HealthTech Funding?
Book a 15-minute call and we'll map your technology to the health-focused programs with the highest probability of success.
Book Strategy Review